Reinventing Hsp90 Inhibitors: Blocking C-Terminal Binding Events to Hsp90 by Using Dimerized Inhibitors
Author:
Affiliation:
1. School of Chemistry; University of New South Wales; Sydney NSW 2052 Australia
2. Department of Bioengineering; University of Utah; Salt Lake City UT 84112 USA
Publisher
Wiley
Subject
General Chemistry,Catalysis,Organic Chemistry
Reference46 articles.
1. Hallmarks of Cancer: The Next Generation
2. Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
3. Tumor Selectivity of Hsp90 Inhibitors: The Explanation Remains Elusive
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches;Cells;2022-03-12
2. Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: Computational modeling and experimental validation;Food and Chemical Toxicology;2019-10
3. A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond;Cold Spring Harbor Perspectives in Biology;2019-04-01
4. Targeting Hsp-90 Related Disease Entities for Therapeutic Development;Heat Shock Proteins;2019
5. Hsp90 Mediates Membrane Deformation and Exosome Release;Molecular Cell;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3